| Original language | English |
|---|---|
| Pages (from-to) | 149-157 |
| Journal | Neoplasia |
| Volume | 23 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2021 |
Funding
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: D.M. Pegtel is a cofounder and CSO of ExBiome BV as well as an advisor to Takeda. This work was supported by grants to D.M. Pegtel by the Dutch Cancer Society (KWF Unique High Risk Project 2017-2; 11308), an NWO (AIMMS STAR Graduate Program grant 022.005.031) to M.P. Bebelman, and a Marie Sklodowska-Curie Fellowship from the European Commission (H2020-MSCA-IF-2018; 845391) to C. Crudden.
| Funders | Funder number |
|---|---|
| Dutch Cancer Society | |
| Horizon 2020 Framework Programme | 845391 |
| European Commission | H2020-MSCA-IF-2018 |
| Nederlandse Organisatie voor Wetenschappelijk Onderzoek | 022.005.031 |
| KWF Kankerbestrijding | 11308 |